RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2007(8): 1311-1313
DOI: 10.1055/s-2007-977452
DOI: 10.1055/s-2007-977452
LETTER
© Georg Thieme Verlag Stuttgart · New York
Stereoselective Synthesis of Novel Δ5-Androstenoarylpyrazoline Derivatives by BF3·OEt2-Induced Intramolecular 1,3-Dipolar Cycloaddition
Weitere Informationen
Received
19 February 2007
Publikationsdatum:
08. Mai 2007 (online)
Publikationsverlauf
Publikationsdatum:
08. Mai 2007 (online)
Abstract
The phenylhydrazones of an unsaturated d-seco-pregnene aldehyde underwent BF3·OEt2-induced intramolecular 1,3-dipolar cycloaddition to afford new pyrazoline-fused Δ5-androstene derivatives under extremely mild conditions. The ring closures occurred stereoselectively in good to excellent yields via the corresponding azomethine imine intermediates and showed marked dependence on the electronic feature of the p-phenyl substituent.
Key words
steroids - hydrazones - 1,3-dipolar cycloaddition - stereoselectivity - Lewis acid
-
1a
Pezdirc LL.Jovanovski V.Bevk D.Jakše R.Pirc S.Meden A.Stanovnik B.Svete J. Tetrahedron 2005, 61: 3977 -
1b
Jones RCF.Hollis SJ.Iley JN. ARKIVOC 2007, (v): 152 -
1c
Norman MH.Heathcock CH. J. Org. Chem. 1987, 52: 226 -
1d
Grashey R. In 1,3-Dipolar Cycloaddition Chemistry Vol. 1:Padwa A. Wiley; New York: 1984. p.734-814 -
2a
Shimizu T.Hayashi Y.Miki M.Teramura K. J. Org. Chem. 1987, 52: 2277 -
2b
Le Fevre G.Hamelin J. Tetrahedron Lett. 1979, 20: 1757 -
2c
Fouchet B.Joucla M.Hamelin J. Tetrahedron Lett. 1981, 22: 1333 -
2d
Le Fevre G.Sinbandhit S.Hamelin J. Tetrahedron 1979, 35: 1821 - 3
Kanemasa S. In 1,3-Dipolar Cycloaddition Chemistry Vol. 1:Padwa A. Wiley; New York: 1984. p.789-797 ; and references cited therein -
4a
Kobayashi S.Shimizu H.Yamashita Y.Ishitani H.Kobayashi J. J. Am. Chem. Soc. 2002, 124: 13678 -
4b
Kobayashi S.Hirabayashi R.Shimizu H.Ishitani H.Yamashita Y. Tetrahedron Lett. 2003, 44: 3351 -
4c
Suga H.Funyu A.Kakehi A. Org. Lett. 2007, 9: 97 -
4d
Yamashita Y.Kobayashi S. J. Am. Chem. Soc. 2004, 126: 11279 -
5a
Bishop JE.Flaxman KA.Orlek BS.Sammes PG.Weller DJ. J. Chem. Soc., Perkin Trans. 1 1995, 2551 -
5b
Sun B.Adachi K.Noguchi M. Tetrahedron 1996, 52: 901 -
5c
Frank É.Wölfling J.Aukszi B.König V.Schneider TR.Schneider G. Tetrahedron 2002, 58: 6843 -
5d
König V.Schneider TR.Frank É.Aukszi B.Schneider G.Wölfling J. Acta Crystallogr., Sect. E: Struct. Rep. Online 2002, 58: o810 -
6a
Hukki J.Laitinen P.Alberty JE. Pharm. Acta Helv. 1968, 43: 704 -
6b
Jung JC.Watkins EB.Avery MA. Heterocycles 2005, 65: 77 -
6c
Fahmy HH.El-Eraky W. Arch. Pharm. Res. 2001, 24: 171 -
6d
Ahn JH.Kim H.-M.Jung SH.Kang SK.Kim KR.Rhee SD.Yang S.-D.Cheon HG.Kim SS. Bioorg. Med. Chem. Lett. 2004, 14: 4461 -
7a
Camoutsis C.Nicolaropoulos S.Catsoulacos P. J. Chem. Eng. 1987, 32: 478 -
7b
Green B.Sheu K. Steroids 1994, 59: 479 -
7c
Schaub RE.van den Hende JH.Weiss MJ. J. Org. Chem. 1965, 30: 2234 -
8a
Hoyte RM.Labaree DC.Fede J.-M.Harris C.Hochberg RB. Steroids 1998, 63: 595 -
8b
Szájli .Wölfling J. Monatsh. Chem. 2006, 137: 1431 -
8c
Labadie SS. J. Org. Chem. 1988, 53: 3284 -
8d
Holt DA.Levy MA.Brandt M.Metcalf BW. Steroids 1986, 48: 213 -
8e
Laitonjam WS.Rajkumar TS.Chingakham BS. Steroids 2002, 67: 203 - 9
Amr AE.-GE.Abdel-Latif NA.Abdalla MM. Bioorg. Med. Chem. 2006, 14: 373 -
10a
Magyar A.Wölfling J.Schneider G. Monatsh. Chem. 2003, 134: 1387 -
10b
Magyar A.Wölfling J.Kubas M.Seijo JAC.Sevvana M.Herbst-Irmer R.Forgó P.Schneider G. Steroids 2004, 69: 301 -
11a
Karabatsos GJ.Taller RA. J. Am. Chem. Soc. 1963, 85: 3624 -
11b
Karabatsos GJ.Shapiro BL.Vane FM.Fleming JS.Ratka JS. J. Am. Chem. Soc. 1963, 85: 2784 -
11c
Bellamy AJ.Hunter J. J. Chem. Soc., Perkin Trans. 1 1976, 456 - 12
Procedure for the Synthesis of 6c
A mixture of 2 (359 mg, 1.00 mmol), 4-methoxyphenyl-hydrazine hydrochloride (3c, 175 mg, 1.00 mmol) and NaOAc (200 mg, 2.44 mmol) in MeOH (5 mL) was stirred for 1 h at r.t. The white precipitate was filtered off and dried to give pure 4c (407 mg, 85%). Compound 4c was dissolved in CH2Cl2 (10 mL) and BF3·OEt2 (0.09 mL, 0.3 mmol) was added dropwise at 0 °C under a nitrogen atmosphere. After 20 min, the reaction was quenched by the addition of 1 M aq NaHCO3 (20 mL). The organic phase was separated, the aqueous phase was extracted with CH2Cl2 (3 × 10 mL) and the combined organic phases were dried over Na2SO4. Evaporation in vacuo and recrystallization from CH2Cl2-hexane afforded 453 mg (95%) of 6c as white crystals; R
f
= 0.32 (EtOAc-CH2Cl2, 10:90). 1H NMR (400 MHz, CDCl3): δ = 0.76 (s, 3 H, 18-H3), 1.05 (s, 3 H, 19-H3), 1.16 (m, 2 H), 1.39 (m, 1 H), 1.44 (d, 3 H, J = 6.0 Hz, 21-H3), 1.51 (m, 1 H), 1.58-1.69 (m, 6 H), 1.80-1.91 (m, 4 H), 2.03 (s, 3 H, 3-Ac-H3), 2.45 (m, 2 H), 2.49 (m, 1 H), 2.77 (d, 1 H, J = 11.2 Hz, 17-H), 3.65 (m, 1 H, 20-H), 3.78 (s, 3 H, 4′-OMe), 4.62 (m, 1 H, 3-H), 5.39 (d, 1 H, J = 4.8 Hz, 6-H), 6.85 (d, 2 H, J = 8.8 Hz, 2′-H, 6′-H), 7.05 (d, 2 H, J = 8.8 Hz, 3′-H, 5′-H). 13C NMR (100 MHz, CDCl3): δ = 14. 4 (C-18), 19.3 (C-19), 20.4 (C-21), 20.7 (CH2), 21.4 (3-Ac-CH3), 25.4 (CH2), 27.7 (CH2), 31.5 (C-8), 31.8 (CH2), 36.8 (C-10), 36.9 (CH2), 37.3 (CH2), 38.1 (CH2), 40.0 (C-13), 50.0 (C-9), 55.6 (4′-OMe), 57.6 (C-14), 61.3 (C-20), 72.2 (C-17), 73.7 (C-3), 114.3 (2 C, C-2′, C-6′), 118.3 (2 C, C-3′, C-5′), 121.9 (C-6), 139.9 (C-5), 142.3 (C-1′), 154.7 (C-4′), 164.3 (C-16), 170.5 (Ac-CO). MS (EI): m/z (relative intensity) = 476 (100) [M+], 461 (18), 187 (30) [C30H40N2O3]